InsiderSignal.AI

InsiderSignal.ai

BHC - Bausch Health Companies Inc.

Insider Purchase by Paulson John (Dir)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Paulson John, serving as Dir at Bausch Health Companies Inc. (BHC), purchased 34,721,118 shares at $9.00 per share, for a total transaction value of $312,490,062.00. Following this transaction, Paulson John now holds 70,755,869 shares of BHC.

This purchase represents a 96.00% increase in Paulson John's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 14, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, August 14, 2025, meaning the disclosure happened on the same day as the trade.

Bausch Health Companies Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Paulson John

Dir

John Paulson is a prominent billionaire investor and the controlling person of Paulson Capital Inc., serving as Non-Executive Chairman of Bausch Health Companies Inc. (BHC) and a director on its board.[[1]](https://www.stocktitan.net/sec-filings/BHC/form-4-bausch-health-companies-inc-insider-trading-activity-ac259a6ee80d.html)[[4]](https://www.marketscreener.com/insider/JOHN-PAULSON-A03Q3A/) He recently acquired 8,992 restricted share units (RSUs) on December 31, 2025, in lieu of cash compensation, bringing his direct ownership to 360,120 BHC shares, with indirect beneficial ownership of 73,255,869 shares through funds managed by his firm.[[1]](https://www.stocktitan.net/sec-filings/BHC/form-4-bausch-health-companies-inc-insider-trading-activity-ac259a6ee80d.html) Earlier, on August 14, 2025, he purchased 34,721,118 shares for approximately $312 million, significantly increasing his stake.[[2]](https://www.investing.com/news/insider-trading-news/paulson-john-buys-312-million-in-bausch-health-bhc-shares-93CH-4194445) Paulson is also an Independent Director at Bausch + Lomb Corp. and Steinway, with a history of major investments in the pharmaceutical sector, including prior stakes in companies like Valeant (now Bausch Health), Salix, Allergan, and others.[[3]](https://www.youtube.com/watch?v=uv3fVKfjNww)[[4]](https://www.marketscreener.com/insider/JOHN-PAULSON-A03Q3A/) Known for value creation through strategic bets, he has been scaling his position in BHC, viewing significant upside potential, including through its 88% ownership in Bausch + Lomb.[[3]](https://www.youtube.com/watch?v=uv3fVKfjNww)

View full insider profile →

Trade Price

$9.00

Quantity

34,721,118

Total Value

$312,490,062.00

Shares Owned

70,755,869

Trade Date

Thursday, August 14, 2025

192 days ago

SEC Filing Date

Thursday, August 14, 2025

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

About Bausch Health Companies Inc.

Company Overview

No company information available
View news mentioning BHC

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/128521

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime